Showing results (501-510 of 936) with videos related to
Sort By:
Pageof 94
European Stroke Journal|September 9, 2024
Endovascular treatment in patients with acute ischemic stroke presenting beyond 6 h after symptom onset: An international multicenter cohort study of the EVA-TRISP collaborationNabila Wali, Lotte J Stolze, Leon A Rinkel, et al.European Stroke Journal|February 28, 2025
Endovascular treatment for isolated cervical internal carotid artery occlusion: ETIICA studyJoão Pedro Marto, Christoph Riegler, Pimrapat Gebert, et al.European Stroke Journal|February 26, 2025
Screening tools for malignancy in patients with cryptogenic stroke: Systematic reviewMaria P Tieck, Constanze Single, Sven Poli, et al.European Stroke Journal|February 7, 2025
First ischemic stroke in young adults: Sex and age-related differences in stroke rates, risk factors, and etiologiesThomas R Schneider, Tolga D Dittrich, Timo Kahles, et al.European Stroke Journal|August 7, 2024
Incidence and nationwide estimates of cryptogenic ischemic stroke or TIA eligible for prolonged cardiac rhythm monitoringYannick Béjot, Gauthier Duloquin, Charles GuenanciaEuropean Stroke Journal|August 30, 2024
Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trialHooman Kamel, Mitchell Sv Elkind, Richard A Kronmal, et al.European Stroke Journal|December 8, 2022
Long-term mortality rates of young stroke in Taiwan: A decade-long epidemiology population-based studyYu-Ying Wu, Po-Yuan Chen, Cheng-Chun Wu, et al.European Stroke Journal|December 8, 2022
Sinus rhythm restoration and improved outcomes in patients with acute ischemic stroke and in-hospital paroxysmal atrial fibrillationDimitrios Sagris, Eleni Korompoki, George Ntaios, et al.European Stroke Journal|January 28, 2020
Building a European 'network of networks' for stroke clinical research - The European Stroke Organisation Trials Alliance (ESOTA)Peter Kelly, Rustam A Salman, Anita Arsovska, et al.European Stroke Journal|January 28, 2020
Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trialH Bart van der Worp, Malcolm R Macleod, Philip Mw Bath, et al.Pageof 94